Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

• Thomas Nyström,
• Irene Santos-Pardo,
• Fredric Hedberg,
• Johan Wardell,
• Nils Witt,
• Yang Cao,
• Yang Cao,
• Leif Bojö,
• Bo Nilsson,
• Johan Jendle

Affiliations

Thomas Nyström

Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

Irene Santos-Pardo

Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

Fredric Hedberg

Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

Johan Wardell

Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

Nils Witt

Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

Yang Cao

Institution of Medical Sciences, Örebro University, Örebro, Sweden

Yang Cao

Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Leif Bojö

Central Hospital, Karlstad, Sweden

Bo Nilsson

Central Hospital, Karlstad, Sweden

Johan Jendle

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden